Vasomedical to Market and Sell EECP Therapy, BIOX ECG Holter and Ambulatory Blood Pressure Monitoring Products in Brazil WESTBURY, N.Y. / ACCESSWIRE / September 2, 2014 / Vasomedical, Inc.(“Vasomedical” or “The Company”) (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP(R) Therapy...
Read More

WESTBURY, NY–(Marketwired – Aug 13, 2014) – Vasomedical, Inc... (“Vasomedical”) (OTCBB: VASO) today reported its operating results for the three months ended June 30, 2014... “We are pleased to report that during the second quarter of 2014 revenue from our Sales Representation Segment increased 4...6% to $6...7 million compared to the same period in 2013...
Read More

WESTBURY, NY / AUGUST 6, 2014 / ACCESSWIRE / Vasomedical, Inc. (OTCBB: VASO) announced today that it will release its financial results for the three months ended June 30, 2014 on Wednesday, August 13, 2014, before markets open. The Company will host a conference call on Wednesday, August 13th at 10:00 a.m. ET featuring remarks by Jun...
Read More

WESTBURY, N.Y., July 16, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (“the Company”) (OTC BB: VASO) today announced the signing on June 27, 2014 of a Value Added Reseller Agreement (“VAR Agreement”) with GE Healthcare (“GEHC”), a division of General Electric Company (NYSE: GE), to become a national value added reseller for GE Healthcare IT’s Radiology...
Read More

WESTBURY, N.Y., May 14, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months ended March 31, 2014. “We are excited to report that during the quarter, the Company generated positive cash flow of $4.2 million from operating activities, mainly due to our VasoHealthcare subsidiary achieving the highest...
Read More